GTx, Inc. (GTXI) to Present on Enobosarm for Muscle Wasting in Non-Small Cell Lung Cancer at an Industry Expert Theater During the 2013 American Society of Clinical Oncology Annual Meeting
5/30/2013 7:11:03 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
GTx, Inc. (Nasdaq: GTXI) announced today that the company will showcase the development of enobosarm at an Industry Expert Theater Presentation on Sunday, June 2nd from 9:45am-10:45am during the upcoming 2013 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
Help employers find you! Check out all the jobs and post your resume.
comments powered by